Goldman Sachs Alternatives
Venture capital
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
7Deep-tech portfolio4 active
3Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: AirNexis Therapeutics
43Co-investorsShare a portfolio company
Portfolio · 7 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| AirNexis Therapeutics | Biotech | Active | Mar 9, 2026 | $62.0M |
| Commonwealth Fusion Systems | Energy | Active | Dec 2, 2021 | $2.0B |
| Newleos | Biotech | Active | — | — |
| Parabilis Medicines | Biotech | Active | — | — |
| Attovia Therapeutics | Biotech | Public | — | — |
| Tempus AI | Medtech | Public | — | — |
| ViceBio | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#60
Portfolio exits#69
Raises, 12 months#22
Co-investors#41
Co-investors
- Frazier Healthcare PartnersVenture capital3 shared
- Cormorant Asset ManagementVenture capital2 shared
- Foresite CapitalVenture capital2 shared
- General CatalystVenture capital2 shared
- GoogleVenture capital2 shared
- RA CapitalVenture capital2 shared
- Redmile GroupVenture capital2 shared
- venBio PartnersVenture capital2 shared
- AmazonVenture capital1 shared
- ARCH VentureVenture capital1 shared
Sectors
- Biotech5
- Energy1
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.